These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 33724474)

  • 1. Outcomes and management of immune thrombocytopenia secondary to COVID-19: Cleveland clinic experience.
    Kewan T; Gunaratne TN; Mushtaq K; Alayan D; Daw H; Haddad A
    Transfusion; 2021 Jul; 61(7):2014-2018. PubMed ID: 33724474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune thrombocytopenia and COVID-19: Case report and review of literature.
    Alonso-Beato R; Morales-Ortega A; Fernández FJH; Morón AIP; Ríos-Fernández R; Rubio JLC; Centeno NO
    Lupus; 2021 Aug; 30(9):1515-1521. PubMed ID: 34053365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics and management of primary and other immune thrombocytopenias: Spanish registry study.
    Palau J; Sancho E; Herrera M; Sánchez S; Mingot ME; Upegui RI; Rodríguez Salazar MJ; de la Cruz F; Fernández MC; González López TJ; Hernández JJ; Ríos E; López-Fernández MF; García M; Hernández JÁ; Sanz MA
    Hematology; 2017 Sep; 22(8):484-492. PubMed ID: 28415913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama.
    Watts RG
    Clin Pediatr (Phila); 2004 Oct; 43(8):691-702. PubMed ID: 15494875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of sarcoidosis and immune thrombocytopenia: presentation and outcome in a series of 20 patients.
    Mahévas M; Chiche L; Uzunhan Y; Khellaf M; Morin AS; Le Guenno G; Péronne V; Affo L; Lidove O; Boutboul D; Dion G; Ducroix JP; Papo T; Pacheco Y; Schleinitz N; Michel M; Godeau B; Valeyre D
    Medicine (Baltimore); 2011 Jul; 90(4):269-278. PubMed ID: 21694642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A real-world study of immune thrombocytopenia management during the COVID-19 pandemic in the UK.
    Rampotas A; Watson E; Burton K; Hill QA; Pavord S
    Br J Haematol; 2022 Jan; 196(2):351-355. PubMed ID: 34448203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contemporary management of primary immune thrombocytopenia in adults.
    Lakshmanan S; Cuker A
    J Thromb Haemost; 2012 Oct; 10(10):1988-98. PubMed ID: 22863415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exacerbation of immune thrombocytopenia following COVID-19 vaccination.
    Kuter DJ
    Br J Haematol; 2021 Nov; 195(3):365-370. PubMed ID: 34075578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of a New 10% Intravenous Immunoglobulin Product in Patients with Primary Immune Thrombocytopenia (ITP).
    Hong J; Bang SM; Mun YC; Yhim HY; Lee J; Lim HS; Oh D;
    J Korean Med Sci; 2018 May; 33(19):e142. PubMed ID: 29736158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of anti-SARS-CoV-2 vaccination for patients with immune thrombocytopenia.
    Crickx E; Moulis G; Ebbo M; Terriou L; Briantais A; Languille L; Limal N; Guillet S; Michel M; Mahevas M; Godeau B
    Br J Haematol; 2021 Dec; 195(5):703-705. PubMed ID: 34467525
    [No Abstract]   [Full Text] [Related]  

  • 11. Immune thrombocytopenic purpura in adults in the last 10 years: single-centre experience.
    Pavkovic M; Trpkovska-Terzieva S; Sotirova T; Latifi A; Cevreska L; Stojanovic A
    Prilozi; 2012; 33(1):121-33. PubMed ID: 22952099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pediatric refractory acute immune thrombocytopenic purpura secondary to asymptomatic SARS-CoV2].
    Dethier A; Gatineau-Sailliant S; Geurten C; Dresse MF
    Rev Med Liege; 2023 Jul; 78(7-8):393-398. PubMed ID: 37560947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnostic approach and treatment of immune thrombocytopenia in adults].
    Kolonić SO; Patekar MB; Milunović V
    Acta Med Croatica; 2013 Mar; 67(1):3-11. PubMed ID: 24279250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinical prediction score for transient versus persistent childhood immune thrombocytopenia.
    Schmidt DE; Wendtland Edslev P; Heitink-Pollé KMJ; Mertens B; Bruin MCA; Kapur R; Vidarsson G; van der Schoot CE; Porcelijn L; van der Bom JG; Rosthøj S; de Haas M
    J Thromb Haemost; 2021 Jan; 19(1):121-130. PubMed ID: 33058474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of idiopathic thrombocytopenic purpura in adults: efficacy of domestic intravenous immunoglobulin in immune thrombocytopenia].
    Pugina SA; Evdokimova NM; Rastorguev GG; Samoĭlova OS; Sorokina IV; Sidnev GV; Vasil'ev DM; Anastasiev VV; Milovidova OV; Molodovskaia EV; Borovkov NN
    Ter Arkh; 1999; 71(8):50-4. PubMed ID: 10515038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune Thrombocytopenia Secondary to COVID-19 Infection.
    Kupietzky A; Parnasa E; Fischer M; Kuint R; Daana M
    Isr Med Assoc J; 2021 Jun; 23(6):342-343. PubMed ID: 34155845
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immune thrombocytopenia preceded by asymptomatic COVID-19 infection].
    Ochiai T; Ando J; Harada S; Hiki M; Ando M; Komatsu N
    Rinsho Ketsueki; 2021; 62(1):58-60. PubMed ID: 33551428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dengue Fever: A Rare Cause Of Immune Thrombocytopenia.
    Ramírez-Fonseca T; Segarra-Torres A; Jaume-Anselmi F; Ramírez-Rivera J
    Bol Asoc Med P R; 2015; 107(2):51-3. PubMed ID: 26434084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Secondary ITP in adults].
    Michel M; Lega JC; Terriou L
    Rev Med Interne; 2021 Jan; 42(1):50-57. PubMed ID: 33139079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful eltrombopag treatment of severe refractory thrombocytopenia in chronic myelomonocytic leukemia: Two cases reports: A CARE-compliant article.
    Gao Y; Gong M; Zhang C; Kong X; Ma Y
    Medicine (Baltimore); 2017 Oct; 96(43):e8337. PubMed ID: 29069007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.